According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected to reach USD 43.11 billion by 2033, growing at a strong CAGR of 8.8% from ...

Medtronic (NYSE:MDT) announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the MiniMed 780G ...

The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and ...

The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and is projected to ...

Medtronic officials today said the planned separation of its Diabetes unit (MiniMed) is on track, with future offerings also ...

Medtronic launches MiniMed 780G with Abbott sensor integration, expanding its diabetes ecosystem ahead of a planned spinoff.

Medtronic has commercially launched its MiniMed 780G system in the US, now integrated with Abbott’s Instinct sensor. The ...

Jeb Denny started at Medtronic on Tuesday in the company’s acute care and monitoring business, which makes pulse oximeters, ...

Medtronic (NYSE: MDT) announced that it appointed Dr. Gerald "Jeb" Denny as chief medical officer for Acute Care & Monitoring ...

The Instinct sensor is based on Abbott's most advanced CGM technology and provides real-time glucose readings, which the system uses to automate insulin adjustments every five minutes.

According to Precedence Research, the global tubeless insulin pump market size will grow from USD 2.92 billion in 2025 to nearly USD 13.65 billion by 2034, with an expected CAGR of 18.74% from 2025 to ...